Literature DB >> 23421632

Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: single-center experience.

Tsunenori Kondo1, Eri Ikezawa, Toshio Takagi, Hirohito Kobayashi, Yasunobu Hashimoto, Junpei Iizuka, Kenji Omae, Kazuhiko Yoshida, Kazunari Tanabe.   

Abstract

OBJECTIVES: To investigate the impact of histological subtypes on the survival of patients presenting with renal cell carcinoma extending into the inferior vena cava.
METHODS: From January 1985 until October 2011, 68 patients with renal cell carcinoma extending into the inferior vena cava underwent radical nephrectomy and inferior vena cava thrombectomy at Tokyo Women's Medical University, Tokyo, Japan. Their clinical and pathological parameters were reviewed from the medical charts.
RESULTS: The median follow up was 19 months (range 0.1-144 months). The tumor thrombus level was I in four patients (6%), II in 38 patients (56%), III in 12 patients (18%) and IV in 14 patients (20%). Papillary histological subtype was found in seven patients (10%), and clear cell in 61 patients (90%). Patients with a papillary subtype had a significantly worse survival outcome than the patients with the clear cell subtype (median survival time 9.0 vs 36.1 months, P < 0.001). Multivariate analysis also showed that the papillary subtype was the only independent prognostic factor for unfavorable cancer-specific survival (P = 0.03). When the patients presented with metastases to lymph nodes or distant metastases, the median survival of the patients with a papillary subtype was extremely short, at just 5.2 months compared with those with a clear cell subtype (24.0 months, P = 0.001).
CONCLUSIONS: Patients with renal cell carcinoma extending into the inferior vena cava with a papillary subtype show a considerably shorter survival compared with those with a clear cell subtype. The papillary renal cell carcinoma extending into the inferior vena cava patient might be an inappropriate candidate for extensive surgery when metastases to nodes or distant organs are found.
© 2013 The Japanese Urological Association.

Entities:  

Keywords:  inferior vena cava; papillary renal cell carcinoma; renal cell carcinoma; survival; thrombectomy; thrombus

Mesh:

Year:  2013        PMID: 23421632     DOI: 10.1111/iju.12123

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  8 in total

Review 1.  Prognostic Benefit of Surgical Management of Renal Cell Carcinoma Invading the Inferior Vena Cava.

Authors:  Aikaterini Mastoraki; Sotiria Mastoraki; Maria Tsikala-Vafea; Ioannis S Papanikolaou; Andreas Lazaris; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Indian J Surg Oncol       Date:  2016-05-04

2.  Bioinformatics Study Identified EGF as a Crucial Gene in Papillary Renal Cell Cancer.

Authors:  GenYi Qu; Hao Wang; Cheng Tang; Guang Yang; Yong Xu
Journal:  Dis Markers       Date:  2022-05-24       Impact factor: 3.464

3.  Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.

Authors:  Xiaonan Chen; Shijie Li; Zhenqun Xu; Kefeng Wang; Donghui Fu; Qiang Liu; Xia Wang; Bin Wu
Journal:  World J Surg Oncol       Date:  2015-02-04       Impact factor: 2.754

4.  The prognostic value and clinicopathological features of sarcomatoid differentiation in patients with renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Zhenlei Zha; Hu Zhao; Yejun Feng; Lijin Zhang; Bin Wu
Journal:  Cancer Manag Res       Date:  2018-06-22       Impact factor: 3.989

5.  A comparison of the prognosis of papillary and clear cell renal cell carcinoma: Evidence from a meta-analysis.

Authors:  Jun Deng; Lei Li; Haimei Xia; Ju Guo; Xin Wu; Xiaorong Yang; Yanyan Hong; Qingke Chen; Jieping Hu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  Prognostic value of CDCA3 in kidney renal papillary cell carcinoma.

Authors:  Hao Li; Mi Li; Caihong Yang; Fengjing Guo; Sisi Deng; Lixi Li; Tian Ma; Jiyuan Yan; Hua Wu; Xiaojuan Li
Journal:  Aging (Albany NY)       Date:  2021-12-14       Impact factor: 5.682

7.  Clinicopathological Features of Papillary Renal Cell Carcinoma With Venous Tumor Thrombus: Case Series from a Large Chinese Center.

Authors:  Zhuo Liu; Liyuan Ge; Xun Zhao; Min Lu; Abudureyimujiang Aili; Yuxuan Li; Guodong Zhu; Peng Hong; Xiaojun Tian; Shumin Wang; Hongxian Zhang; Cheng Liu; Zhenshan Ding; Shudong Zhang; Lulin Ma
Journal:  Clin Med Insights Oncol       Date:  2022-04-17

8.  Histological features suggestive of survival in patients with renal cell carcinoma and tumor thrombus: A single-center experience.

Authors:  Tao Wang; Yan Huang; Luojia Yang; Yang Yang; Di Li; Xiangyi Zhang; Xiaohui Ding; Baojun Wang; Xin Ma
Journal:  Front Oncol       Date:  2022-09-05       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.